This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Mesopram
Description: Mesopram is a novel potent and selective PDE IV inhibitor. Inhibition of type IV phosphodiesterase (PDE IV) in animals with EAE (multiple sclerosis-like disease) has shown to result in amelioration of disease symptoms.
Deal Structure: In 2006, Bayer acquired Schering AG.
Additional information available to subscribers only: